NO972927L - 19-nor-progesteronderivater med 14<alfa>,17<beta>-C2-bro - Google Patents

19-nor-progesteronderivater med 14<alfa>,17<beta>-C2-bro

Info

Publication number: NO972927L
Authority: NO; Norway
Prior art keywords: alfa; beta; bridge; progesterone derivatives; progesterone
Prior art date: 1994-12-23

Application number

NO972927A

Other languages

English (en)

Other versions

NO310198B1 (no

NO972927D0 (no

Inventor

Klaus Schoellkopf

Wolfgang Halfbrodt

Joachim Kuhnke

Wolfgang Schwede

Karl-Heinrich Fritzemeier

Rolf Krattenmacher

Hans-Peter Muhn

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-23

Filing date

1997-06-23

Publication date

1997-08-22

1997-06-23 Application filed by Schering Ag filed Critical Schering Ag

1997-06-23 Publication of NO972927D0 publication Critical patent/NO972927D0/no

1997-08-22 Publication of NO972927L publication Critical patent/NO972927L/no

2001-06-05 Publication of NO310198B1 publication Critical patent/NO310198B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO19972927A 1994-12-23 1997-06-23 19-norprogesteronderivater med 14<alfa>,17<beta>-C2-bro, farmasöytisk preparat og mellomprodukter for fremstilling avforbindelsene NO310198B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4447401A DE4447401A1 (de)	1994-12-23	1994-12-23	14,17-C¶2¶-überbrückte Steroide
PCT/EP1995/005107 WO1996020209A2 (de)	1994-12-23	1995-12-23	14α,17α-C2-ÜBERBRÜCKTE 19-NOR-PROGESTERONDERIVATE

Publications (3)

Publication Number	Publication Date
NO972927D0 NO972927D0 (no)	1997-06-23
NO972927L true NO972927L (no)	1997-08-22
NO310198B1 NO310198B1 (no)	2001-06-05

Family

ID=6537601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19972927A NO310198B1 (no)	1994-12-23	1997-06-23	19-norprogesteronderivater med 14<alfa>,17<beta>-C2-bro, farmasöytisk preparat og mellomprodukter for fremstilling avforbindelsene

Country Status (33)

Country	Link
US (3)	US5827842A (no)
EP (1)	EP0799238B1 (no)
JP (1)	JPH10511379A (no)
KR (1)	KR100400621B1 (no)
CN (1)	CN1109689C (no)
AR (1)	AR002263A1 (no)
AT (1)	ATE193300T1 (no)
AU (1)	AU692346B2 (no)
BG (1)	BG63274B1 (no)
CA (1)	CA2208605C (no)
CZ (1)	CZ292696B6 (no)
DE (2)	DE4447401A1 (no)
DK (1)	DK0799238T3 (no)
EE (1)	EE03356B1 (no)
ES (1)	ES2151612T3 (no)
FI (1)	FI972624A0 (no)
GR (1)	GR3034261T3 (no)
HU (1)	HUP0600457A2 (no)
IL (1)	IL116504A (no)
LT (1)	LT4295B (no)
LV (1)	LV11954B (no)
NO (1)	NO310198B1 (no)
NZ (1)	NZ298770A (no)
PL (1)	PL182642B1 (no)
PT (1)	PT799238E (no)
RO (1)	RO119366B1 (no)
RU (1)	RU2169153C2 (no)
SI (1)	SI9520137A (no)
SK (1)	SK282281B6 (no)
TW (1)	TW333536B (no)
UA (1)	UA45382C2 (no)
WO (1)	WO1996020209A2 (no)
ZA (1)	ZA9510923B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0931047A1 (en) *	1996-09-03	1999-07-28	The Trustees of Columbia University in the City of New York	Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
DE19848305C1 (de) *	1998-10-14	2000-05-25	Schering Ag	Verfahren zur Umsetzung von substituierten Propargylalkoholen in Gegenwart von sauren Ionenaustauschern und Zwischenprodukte des Verfahrens
DE19848303A1 (de) *	1998-10-14	2000-04-20	Schering Ag	Kombination aus Gestagenen und Zuckern
EP1216699A1 (de) *	2000-12-21	2002-06-26	Schering Aktiengesellschaft	Transdermalsystem enthaltend ein hochpotentes Gestagen
KR20050038580A (ko) *	2001-10-26	2005-04-27	악조 노벨 엔.브이.	주요 우울 장애의 치료에 사용되는(11β,17β)-11-(1,3-벤조디옥솔-5-일)-17-히드록시-17-(1-프로피닐)-에스트라-4,9-디엔-3-온의 용도
DE102007063503A1 (de) *	2007-12-29	2009-07-02	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3628189A1 (de)	1986-08-20	1988-02-25	Schering Ag	Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de)	1993-08-02	1995-02-09	Schering Ag	15,15-Dialkyl-substituierte Derivate des Estradiols

1994
- 1994-12-23 DE DE4447401A patent/DE4447401A1/de not_active Withdrawn
1995
- 1995-12-21 ZA ZA9510923A patent/ZA9510923B/xx unknown
- 1995-12-22 AR ARP950100723A patent/AR002263A1/es unknown
- 1995-12-22 IL IL11650495A patent/IL116504A/en not_active IP Right Cessation
- 1995-12-23 AT AT95943195T patent/ATE193300T1/de not_active IP Right Cessation
- 1995-12-23 EE EE9700142A patent/EE03356B1/xx not_active IP Right Cessation
- 1995-12-23 SI SI9520137A patent/SI9520137A/sl not_active IP Right Cessation
- 1995-12-23 NZ NZ298770A patent/NZ298770A/en unknown
- 1995-12-23 DE DE59508403T patent/DE59508403D1/de not_active Expired - Fee Related
- 1995-12-23 CN CN95197047A patent/CN1109689C/zh not_active Expired - Fee Related
- 1995-12-23 AU AU44338/96A patent/AU692346B2/en not_active Ceased
- 1995-12-23 HU HU0600457A patent/HUP0600457A2/hu not_active Application Discontinuation
- 1995-12-23 UA UA97073911A patent/UA45382C2/uk unknown
- 1995-12-23 CZ CZ19971954A patent/CZ292696B6/cs not_active IP Right Cessation
- 1995-12-23 PL PL95320799A patent/PL182642B1/pl not_active IP Right Cessation
- 1995-12-23 JP JP8520205A patent/JPH10511379A/ja not_active Ceased
- 1995-12-23 DK DK95943195T patent/DK0799238T3/da active
- 1995-12-23 EP EP95943195A patent/EP0799238B1/de not_active Expired - Lifetime
- 1995-12-23 ES ES95943195T patent/ES2151612T3/es not_active Expired - Lifetime
- 1995-12-23 RU RU97112100/04A patent/RU2169153C2/ru not_active IP Right Cessation
- 1995-12-23 RO RO97-01062A patent/RO119366B1/ro unknown
- 1995-12-23 WO PCT/EP1995/005107 patent/WO1996020209A2/de not_active Ceased
- 1995-12-23 PT PT95943195T patent/PT799238E/pt unknown
- 1995-12-23 CA CA002208605A patent/CA2208605C/en not_active Expired - Fee Related
- 1995-12-23 SK SK788-97A patent/SK282281B6/sk unknown
- 1995-12-23 KR KR1019970704251A patent/KR100400621B1/ko not_active Expired - Fee Related
- 1995-12-26 US US08/578,847 patent/US5827842A/en not_active Expired - Fee Related
1996
- 1996-01-25 TW TW085100899A patent/TW333536B/zh not_active IP Right Cessation
1997
- 1997-06-03 BG BG101554A patent/BG63274B1/bg unknown
- 1997-06-18 FI FI972624A patent/FI972624A0/fi unknown
- 1997-06-20 LV LVP-97-125A patent/LV11954B/lv unknown
- 1997-06-20 LT LT97-106A patent/LT4295B/lt not_active IP Right Cessation
- 1997-06-23 NO NO19972927A patent/NO310198B1/no unknown
1998
- 1998-08-18 US US09/135,483 patent/US5973172A/en not_active Expired - Fee Related
1999
- 1999-07-28 US US09/362,214 patent/US6147065A/en not_active Expired - Fee Related
2000
- 2000-08-24 GR GR20000401948T patent/GR3034261T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1171115A (zh)	1998-01-21
IL116504A (en)	2001-11-25
JPH10511379A (ja)	1998-11-04
CN1109689C (zh)	2003-05-28
WO1996020209A3 (de)	1996-09-06
CA2208605C (en)	2008-07-15
DK0799238T3 (da)	2000-10-09
EP0799238A2 (de)	1997-10-08
KR100400621B1 (ko)	2004-02-05
LT97106A (en)	1997-10-27
FI972624A7 (fi)	1997-06-18
CZ195497A3 (cs)	1998-03-18
ES2151612T3 (es)	2001-01-01
UA45382C2 (uk)	2002-04-15
RU2169153C2 (ru)	2001-06-20
SI9520137A (sl)	1998-02-28
CA2208605A1 (en)	1996-07-04
CZ292696B6 (cs)	2003-11-12
ZA9510923B (en)	1996-07-04
NO310198B1 (no)	2001-06-05
MX9704774A (es)	1997-10-31
LV11954A (lv)	1998-01-20
SK282281B6 (sk)	2002-01-07
PL320799A1 (en)	1997-10-27
ATE193300T1 (de)	2000-06-15
BG101554A (en)	1998-09-30
EE03356B1 (et)	2001-02-15
RO119366B1 (ro)	2004-08-30
BG63274B1 (bg)	2001-08-31
US6147065A (en)	2000-11-14
SK78897A3 (en)	1997-12-10
EP0799238B1 (de)	2000-05-24
AU692346B2 (en)	1998-06-04
TW333536B (en)	1998-06-11
FI972624A0 (fi)	1997-06-18
DE4447401A1 (de)	1996-07-04
US5827842A (en)	1998-10-27
AR002263A1 (es)	1998-03-11
LV11954B (lv)	1998-06-20
NO972927D0 (no)	1997-06-23
DE59508403D1 (de)	2000-06-29
US5973172A (en)	1999-10-26
LT4295B (lt)	1998-02-25
AU4433896A (en)	1996-07-19
GR3034261T3 (en)	2000-12-29
WO1996020209A2 (de)	1996-07-04
HUP0600457A2 (en)	2006-08-28
PT799238E (pt)	2000-11-30
NZ298770A (en)	1999-10-28
IL116504A0 (en)	1996-03-31
PL182642B1 (pl)	2002-02-28

Publication	Publication Date	Title
FI934919A0 (fi)	1993-11-05	Avgivningssystem med kontrollerad, foerlaengd frigivning foer roekavvaenjning
DE59501802D1 (de)	1998-05-14	Substituierte 1H-3-Aryl-pyrrolidin-2,4-dion-Derivate
NO920137L (no)	1992-07-13	Blindnaglemutter med trekkdor
NL300150I2 (nl)	2004-09-01	4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
FI924389L (fi)	1992-09-30	Finfoerdelade, absorberande polymerkompositioner innehaollande aggregat med inboerdes tvaerbundna partiklar
BR9508318A (pt)	1997-12-23	Composição impadora concentrada
DE69528197D1 (de)	2002-10-17	Neue 1,3-dialkylharnstoff-derivate
FI952424L (fi)	1995-11-20	11,21-bisfenyyli-19-norpregaanijohdannaisia
IS5402A (is)	2000-03-14	Útskiptar króman afleiður
NO982473L (no)	1998-12-03	5'-Deoksy-cytidin derivater
DK1027361T3 (da)	2003-08-25	Derivater af erythromycin med 6,11-bro
DE69716901D1 (de)	2002-12-12	2,4-diaminopyrimidin-derivate
NO20013013L (no)	2001-06-18	<alfa>v<beta>6-integrininhibitorer
IS5403A (is)	2000-03-14	Útskiptar króman afleiður
NO971248D0 (no)	1997-03-18	5<alfa>-reduktaseinhibitorer
NO893524D0 (no)	1989-09-01	Piperazindioner med psykotrop virkning.
FI931459L (fi)	1993-10-02	Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
NO972927L (no)	1997-08-22	19-nor-progesteronderivater med 14<alfa>,17<beta>-C2-bro
DE69714358D1 (de)	2002-09-05	9,10-disubstituierte campothecinderivate mit antitumoraktivität
FI912127A7 (fi)	1991-11-04	Effektivt delar utnyttjande, minnesbaserad funktionskrets med väljbara transmissionsegenskaper
DE69519515D1 (de)	2001-01-04	Selbstaufzeichnendes transferband
ATE243218T1 (de)	2003-07-15	2''-deoxyhygromycinderivate
ES1027890Y (es)	1995-04-01	Pieza ceramica perfeccionada.
FI921760L (fi)	1993-01-12	Viskoelastisk vattenhaltig flytande detergentkomposition, speciellt foer automatiska diskmaskiner med foerbaettrad doserbarhet
FI954132L (fi)	1996-03-03	Diastrofisen dysplasian geeni